Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.55
-0.1700-0.61%
Post-market: 27.54-0.0115-0.04%19:59 EDT
Volume:40.44M
Turnover:1.11B
Market Cap:156.64B
PE:36.26
High:27.66
Open:27.62
Low:27.25
Close:27.72
52wk High:29.21
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:1.41
T/O Rate:0.72%
Dividend:1.72
Dividend Rate:6.24%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.84
PE(LYR):20.19

Loading ...

Pfizer Ramps Up Obesity And Eczema Bets, Investors Watch

TIPRANKS
·
Sep 05

Pfizer Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Pfizer’s Next Move in Obesity Drugs: What the New VESPER-JM Trial Means for PFE Investors

TIPRANKS
·
Sep 05

Pfizer Steps Up in Obesity Race With New Phase 3 Berobenatide Trial in Japan

TIPRANKS
·
Sep 05

Pfizer’s Tilrekimig Eczema Trial: A Fresh Phase 3 Catalyst for PFE Investors

TIPRANKS
·
Sep 05

Pfizer’s Migraine Tablet Study Wraps Up, Supporting Pipeline Flexibility for PFE Investors

TIPRANKS
·
Sep 05

Pfizer Announces Q3 2026 Dividend of R$ 0.37 Per Unit for Brpfizbdr 006

Reuters
·
Sep 03

Medicus Pharma Shares Down 20.5% Premarket; Co, Pfizer Enter Licensing Deal for Experimental Cancer Therapy

THOMSON REUTERS
·
Sep 03

Medicus Pharma Surges on Pfizer Licensing Deal for Experimental Cancer Therapy

Reuters
·
Sep 03

Medicus Pharma Signs Co-Development, Licensing Deal with Pfizer for Cd228v Antibody-Drug Conjugate

Reuters
·
Sep 03

Medicus Pharma - Pays Pfizer $12 Mln Upfront, $15 Mln Due on First Anniversary - SEC Filing

THOMSON REUTERS
·
Sep 03

Medicus Pharma - Pfizer Paid the Company a One-Time, Non-Refundable Payment of $2.0 Million

THOMSON REUTERS
·
Sep 03

Medicus Pharma - Enters Co-Development and License Agreement with Pfizer on Sept 2, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 03

NYSE Most Active Issues

Dow Jones
·
Sep 03

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Pfizer’s New Asthma Candidate PF-08103402 Enters Phase 1: What Investors Should Know

TIPRANKS
·
Sep 03

Top AI Healthcare Stocks For September 2026

Simply Wall St.
·
Sep 02

Pfizer (PFE) Following FDA Vaccine Approval Has Fair Value Back In Focus

Simply Wall St.
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Did Targeted XFG COVID Shots Just Recenter Pfizer's (PFE) Post‑Pandemic Investment Narrative?

Simply Wall St.
·
Sep 01